BDNF Expression in the Aged and AD Brain and Its Expression in Relation to Cytoskeletal Proteins
CSEF · 2002 Biochemistry/ Molecular Biology
Overview
Objectives/Goals My objective is to better understand Alzheimer's disease through fluorescent immunohistochemistry and double labeling. 1) Establish the distribution of BDNF (brain-derived neurotrophic factor) in the control (normal) aged brains and late AD brains. 2) Show changes in cytoskeletal aspects from normal to AD brains. 3) Find a correlation between BDNF and cytoskeletal proteins. I hypothesize that both BDNF and cytoskeletal labeling will decrease from aged to AD brains. Methods/Materials Major materials used inclue: humman brain tissues (frontal cortex), vibratome, vacuum, orbit shaker, fluoroboxes, microscope slides and coverslips, fluorescent microscope, mercury lamp, permafluor, and primary and secondary antibodies. Completion of my experiment involved 4 basic steps. 1) Obtain brain cases (6) from the tissue repository at UCI and cut them into thin slices using a vibratome. 2) Use fluorescent immunohistochemistry and double labeling to label BDNF and cytoskeletal structures (including washes, primary antibody, and secondary antibody) 3) Mount tissues on slides (8 tissues per case x 6 cases = 48 tissue samples) and coverslip them. 4) View all slides under a fluorescent microscope and determine levels of BDNF and cytoskeletal proteins. Results Trends are exhibited. The amount of BDNF decreased slightly from normal to AD brains while the amount of cytoskeletal proteins increased more dramatically. There was a negative correlation between BDNF and cytoskeletal proteins. Conclusions/Discussion BDNF and cytoskeletal proteins both play crucual roles in AD. BDNF is lost with aging, but those who lose too much of this neurotrophin develop AD. Cytoskeletal proteins are increased because as AD attacks, more proteins are required to maintain structure and rigidity. My hypothesis was only partially correct, as I predicted correctly that BDNF levels would decrease but while I though cytoskeletal amounts would decrease, the results show that they increased.
Summary statement
My project is about differences between normal and AD (Alzheimer disease) brains, focusing on the changes in BDNF (brain-derived neurotrophic factor) and its relationship to cytoskeletal aspects.
Help received
Used equipment at the Institute of Brain Aging and Dementia of the University of California, Irvine, under the supervision of Dr. Paul Adlard
Competition history
- CSEF 2002
Resources
Related projects
ISEF · 2021
Investigating Bone Morphogenetic Protein 4 as a Potential Regulator of the Age Related Increase in Risk for Alzheimer’s Disease: The Regulation of the Unfolded Protein Response and Apolipoprotein E Expression in Astrocytes
ISEF · 2016
Biochemical Characterization and Imaging of Arc: Insights into Neurodegeneration and Alzheimer’s Development
CSEF · 2016
Development of a Novel Microfluidic System to Study Neurodegenerative Disorders
CSEF · 2010
Alzheimer's and Inflammation: Exploring Enzymatic Pathways Involved in Beta Amyloid Induced TNF alpha Production
CSEF · 2002
Age and Lesion-Induced Changes in Protease Nexin 1 Expression in the Brain
ISEF · 2014
Moving Towards the Cure for Alzheimer's Disease: The Effects of Histone Deacetylase Inhibitors on Neurofibrillary Tangle Formation and Microtubule Stability to Preserve Neuronal Integrity (A Novel in vitro Trial)
ISEF · 2017
Moving Towards the Cure: Investigating the Effect of cAMP-Dependent Molecular Mechanisms on the Regulation of MAPT Gene Expression and the Formation of Neurofibrillary Tangles to Identify Drug Targets for Alzheimer's Disease
CSEF · 2011
Striking a Blow for Alzheimer's Disease: Role of ApoE Mediated Inflammatory Pathways on Tau Phosphorylation
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects